These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |||||||
For the quarterly period ended |
|
|||||||
|
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |||||||
For the transition period from to |
|
|
||||||||||
(State or Other Jurisdiction of
Incorporation or Organization)
|
(I.R.S. Employer
Identification No.) |
||||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
$0.01 par value per share |
|
|
|
☒
|
Accelerated filer |
☐
|
||||||||
Non-accelerated filer |
☐
|
Smaller reporting company |
|
||||||||
Emerging growth company |
|
Class | Number of Shares | |||||||
Class A Common Stock, par value $0.01 per share |
|
Page | ||||||||
PART I. | ||||||||
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
PART II. | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 5. | ||||||||
Item 6. | ||||||||
Defined Term | Definition | |||||||
10b5-1 Plan
|
Trading plan adopted pursuant to Rule 10b5-1 under the Exchange Act
|
|||||||
Adjusted Diluted EPS | Adjusted diluted earnings per share | |||||||
AI
|
Artificial intelligence
|
|||||||
ASC | Accounting Standards Codification | |||||||
CC | Constant Currency | |||||||
CE | Continental Europe | |||||||
CITA | Commissioner of Income Tax (Appeals) in India | |||||||
CMT | Communications, Media and Technology | |||||||
CODM
|
Chief Operating Decision Maker
|
|||||||
Credit Agreement |
Credit agreement with a commercial bank syndicate dated April 18, 2024, as amended
|
|||||||
CTS India | Our principal operating subsidiary in India | |||||||
DOJ | United States Department of Justice | |||||||
DSO | Days Sales Outstanding | |||||||
DTSA | Defend Trade Secrets Act | |||||||
EPS | Earnings per share | |||||||
ESG
|
Environmental, social and corporate governance
|
|||||||
EU | European Union | |||||||
Exchange Act | Securities Exchange Act of 1934, as amended | |||||||
FS | Financial Services | |||||||
GAAP | Generally Accepted Accounting Principles in the United States of America | |||||||
GenAI
|
Generative artificial intelligence
|
|||||||
HS | Health Sciences | |||||||
High Court | Madras, India High Court | |||||||
India Defined Contribution Obligation | Certain statutory defined contribution obligations of employees and employers in India | |||||||
IRS | Internal Revenue Service | |||||||
ITAT
|
Income Tax Appellate Tribunal in India
|
|||||||
ITD | Indian Income Tax Department | |||||||
NA | North America | |||||||
Ninth Circuit
|
United States Court of Appeals for the Ninth Circuit
|
|||||||
OECD
|
Organization for Economic Cooperation and Development
|
|||||||
P&R | Products & Resources | |||||||
Recently completed acquisitions
|
Acquisitions that were completed in the 12 months preceding the beginning of the reporting period (in order to identify the impact of such acquisitions for the first twelve months of ownership)
|
|||||||
RoW | Rest of World | |||||||
SCI | Supreme Court of India | |||||||
SEC | United States Securities and Exchange Commission | |||||||
Second Circuit | United States Court of Appeals for the Second Circuit | |||||||
SG&A | Selling, general and administrative | |||||||
Syntel |
Syntel Sterling Best Shores Mauritius Ltd.
|
|||||||
Tax Reform Act | Tax Cuts and Jobs Act | |||||||
Term Loan | Unsecured term loan under the Credit Agreement | |||||||
TriZetto |
The TriZetto Group, Inc., now known as Cognizant Technology Software Group, Inc.
|
|||||||
UK | United Kingdom | |||||||
USDC-CDCA |
United States District Court for the Central District of California
|
|||||||
USDC-NJ | United States District Court for the District of New Jersey | |||||||
USDC-SDNY
|
United States District Court for the Southern District of New York |
Cognizant Technology Solutions |
1
|
September 30, 2024 Form 10-Q
|
Forward Looking Statements |
Cognizant Technology Solutions |
2
|
September 30, 2024 Form 10-Q
|
Cognizant Technology Solutions |
3
|
September 30, 2024 Form 10-Q
|
(in millions, except par values) | September 30, 2024 | December 31, 2023 | |||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Short-term investments |
|
|
|||||||||
Trade accounts receivable, net |
|
|
|||||||||
Other current assets |
|
|
|||||||||
Total current assets |
|
|
|||||||||
Property and equipment, net |
|
|
|||||||||
Operating lease assets, net |
|
|
|||||||||
Goodwill |
|
|
|||||||||
Intangible assets, net |
|
|
|||||||||
Deferred income tax assets, net |
|
|
|||||||||
Long-term investments |
|
|
|||||||||
Other noncurrent assets |
|
|
|||||||||
Total assets | $ |
|
$ |
|
|||||||
Liabilities and Stockholders’ Equity | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ |
|
$ |
|
|||||||
Deferred revenue |
|
|
|||||||||
Short-term debt |
|
|
|||||||||
Operating lease liabilities |
|
|
|||||||||
Accrued expenses and other current liabilities |
|
|
|||||||||
Total current liabilities |
|
|
|||||||||
Deferred revenue, noncurrent |
|
|
|||||||||
Operating lease liabilities, noncurrent |
|
|
|||||||||
Deferred income tax liabilities, net |
|
|
|||||||||
Long-term debt |
|
|
|||||||||
Long-term income taxes payable |
|
|
|||||||||
Other noncurrent liabilities |
|
|
|||||||||
Total liabilities |
|
|
|||||||||
|
|
||||||||||
Stockholders’ equity: | |||||||||||
Preferred stock, $
|
|
|
|||||||||
Class A common stock, $
|
|
|
|||||||||
Additional paid-in capital |
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Accumulated other comprehensive income (loss) |
|
(
|
|||||||||
Total stockholders’ equity |
|
|
|||||||||
Total liabilities and stockholders’ equity | $ |
|
$ |
|
Cognizant Technology Solutions |
4
|
September 30, 2024 Form 10-Q
|
(in millions, except per share data)
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Revenues | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Cost of revenues (exclusive of depreciation and amortization expense shown separately below) |
|
|
|
|
|||||||||||||||||||
Selling, general and administrative expenses |
|
|
|
|
|||||||||||||||||||
Restructuring charges |
|
|
|
|
|||||||||||||||||||
Depreciation and amortization expense |
|
|
|
|
|||||||||||||||||||
Income from operations |
|
|
|
|
|||||||||||||||||||
Other income (expense), net: | |||||||||||||||||||||||
Interest income |
|
|
|
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Foreign currency exchange gains (losses), net |
(
|
|
(
|
|
|||||||||||||||||||
Other, net |
|
|
|
|
|||||||||||||||||||
Total other income (expense), net |
|
|
|
|
|||||||||||||||||||
Income before provision for income taxes |
|
|
|
|
|||||||||||||||||||
Provision for income taxes |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Income (loss) from equity method investments |
|
|
|
|
|||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Weighted average number of common shares outstanding - Basic |
|
|
|
|
|||||||||||||||||||
Dilutive effect of shares issuable under stock-based compensation plans |
|
|
|
|
|||||||||||||||||||
Weighted average number of common shares outstanding - Diluted |
|
|
|
|
Cognizant Technology Solutions |
5
|
September 30, 2024 Form 10-Q
|
(in millions)
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Change in Accumulated other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Foreign currency translation adjustments |
|
(
|
|
(
|
|||||||||||||||||||
Unrealized gains and losses on cash flow hedges |
(
|
(
|
|
|
|||||||||||||||||||
Other comprehensive income (loss) |
|
(
|
|
|
|||||||||||||||||||
Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
Cognizant Technology Solutions |
6
|
September 30, 2024 Form 10-Q
|
(in millions, except per share data)
|
Class A Common Stock |
Additional
Paid-in Capital |
Retained
Earnings |
Accumulated
Other Comprehensive Income (Loss) |
Total Stockholders' Equity
|
|||||||||||||||||||||||||||||||||
Shares | Amount | |||||||||||||||||||||||||||||||||||||
Balance, December 31, 2023
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||
Common stock issued, stock-based compensation plans |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
Repurchases of common stock |
(
|
— |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Balance, March 31, 2024
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||
Common stock issued, stock-based compensation plans |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
Repurchases of common stock |
(
|
— |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Balance, June 30, 2024
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||
Common stock issued, stock-based compensation plans |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
Common stock issued, acquisition related
|
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
Repurchases of common stock |
(
|
— |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Balance, September 30, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
Cognizant Technology Solutions |
7
|
September 30, 2024 Form 10-Q
|
(in millions, except per share data)
|
Class A Common Stock |
Additional
Paid-in Capital |
Retained
Earnings |
Accumulated
Other Comprehensive Income (Loss) |
Total Stockholders' Equity
|
|||||||||||||||||||||||||||||||||
Shares | Amount | |||||||||||||||||||||||||||||||||||||
Balance, December 31, 2022
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||
Common stock issued, stock-based compensation plans |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
Repurchases of common stock |
(
|
— |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Balance, March 31, 2023 |
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||
Common stock issued, stock-based compensation plans |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
Repurchases of common stock |
(
|
— |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Balance, June 30, 2023 |
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||
Common stock issued, stock-based compensation plans | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
Repurchases of common stock |
(
|
— |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||
Balance, September 30, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
Cognizant Technology Solutions |
8
|
September 30, 2024 Form 10-Q
|
(in millions)
|
For the Nine Months Ended
September 30, |
||||||||||
2024 | 2023 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ |
|
$ |
|
|||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation and amortization |
|
|
|||||||||
Deferred income taxes |
(
|
(
|
|||||||||
Stock-based compensation expense |
|
|
|||||||||
Other |
|
|
|||||||||
Changes in assets and liabilities, net of the effect of business combinations: | |||||||||||
Trade accounts receivable, current |
(
|
(
|
|||||||||
Other current and noncurrent assets |
(
|
|
|||||||||
Accounts payable |
(
|
(
|
|||||||||
Deferred revenues, current and noncurrent |
(
|
(
|
|||||||||
Other current and noncurrent liabilities |
(
|
(
|
|||||||||
Net cash provided by operating activities |
|
|
|||||||||
Cash flows from investing activities: | |||||||||||
Purchases of property and equipment |
(
|
(
|
|||||||||
Purchases of available-for-sale investment securities |
|
(
|
|||||||||
Proceeds from maturity or sale of available-for-sale investment securities |
|
|
|||||||||
Purchases of held-to-maturity investment securities |
|
(
|
|||||||||
Proceeds from maturity of held-to-maturity investment securities |
|
|
|||||||||
Purchases of other investments |
(
|
(
|
|||||||||
Proceeds from maturity or sale of other investments |
|
|
|||||||||
Payments for business combinations, net of cash acquired |
(
|
(
|
|||||||||
Net cash (used in) investing activities |
(
|
(
|
|||||||||
Cash flows from financing activities: | |||||||||||
Issuance of common stock under stock-based compensation plans |
|
|
|||||||||
Repurchases of common stock |
(
|
(
|
|||||||||
Repayment of Term Loan borrowings and earnout and finance lease obligations
|
(
|
(
|
|||||||||
Proceeds from borrowings under the revolving credit facility |
|
|
|||||||||
Dividends paid |
(
|
(
|
|||||||||
Net cash (used in) financing activities |
(
|
(
|
|||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents
|
(
|
(
|
|||||||||
(Decrease) in cash, cash equivalents and restricted cash and cash equivalents
|
(
|
(
|
|||||||||
Cash, cash equivalents and restricted cash and cash equivalents beginning of year
|
|
|
|||||||||
Cash and cash equivalents, end of period | $ |
|
$ |
|
Cognizant Technology Solutions |
9
|
September 30, 2024 Form 10-Q
|
Note 1 — Interim Consolidated Financial Statements |
Date Issued and Topic |
Effective Date
|
Description | Impact | ||||||||
November 2023
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
|
Annual period starting in 2024 and interim periods starting in 2025
Retrospective basis |
The standard requires enhanced segment disclosures but does not change the definition of a segment or the guidance for determining a reportable segment. The amendments require disclosure of significant segment expenses regularly provided to the CODM included within segment operating profit or loss and a description of how the CODM utilizes segment operating profit or loss to assess segment performance and allocate resources. The new standard also allows companies to disclose multiple measures of segment profit or loss if those measures are used to allocate resources.
|
The adoption of the new standard is not expected to have a significant impact on our disclosures.
|
||||||||
December 2023
Income Taxes (Topic 740): Improvements to Income Tax Disclosures
|
Annual period starting in 2025
Prospective basis although retrospective application is permitted |
The standard requires enhanced income tax disclosures primarily related to the income tax rate reconciliation and income taxes paid information.
|
The Company is currently evaluating the impact of the new standard on its disclosures.
|
||||||||
Cognizant Technology Solutions |
10
|
September 30, 2024 Form 10-Q
|
Note 2 — Revenues and Trade Accounts Receivable |
Three Months Ended
September 30, 2024 |
Nine Months Ended
September 30, 2024 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | FS | HS | P&R | CMT | Total | FS | HS | P&R | CMT | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Geography: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
North America | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
United Kingdom |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Continental Europe |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Europe - Total |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Rest of World |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Service line: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consulting and technology services | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Outsourcing services |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Type of contract: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Time and materials | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Fixed-price |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Transaction or volume-based |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Cognizant Technology Solutions |
11
|
September 30, 2024 Form 10-Q
|
Three Months Ended
September 30, 2023 |
Nine Months Ended
September 30, 2023 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | FS | HS | P&R | CMT | Total | FS | HS | P&R | CMT | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Geography: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
North America | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
United Kingdom |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Continental Europe |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Europe - Total |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Rest of World |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Service line: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consulting and technology services | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Outsourcing services |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Type of contract: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Time and materials | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Fixed-price |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Transaction or volume-based |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
(in millions) | 2024 | 2023 | ||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Costs capitalized |
|
|
||||||||||||
Amortization expense |
(
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
(in millions) | 2024 | 2023 | ||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Revenues recognized during the period but not billed |
|
|
||||||||||||
Amounts reclassified to trade accounts receivable |
(
|
(
|
||||||||||||
Amounts acquired in business combinations |
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
Cognizant Technology Solutions |
12
|
September 30, 2024 Form 10-Q
|
(in millions) | 2024 | 2023 | ||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Amounts billed but not recognized as revenues |
|
|
||||||||||||
Revenues recognized related to the beginning balance of deferred revenue |
(
|
(
|
||||||||||||
Amounts acquired in business combinations |
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
(in millions) | 2024 | 2023 | ||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Credit loss expense
(1)
|
|
|
||||||||||||
Write-offs charged against the allowance |
(
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
Note 3 — Business Combinations |
Cognizant Technology Solutions |
13
|
September 30, 2024 Form 10-Q
|
(in millions) |
Thirdera
|
Belcan
|
Total | Weighted Average Useful Life | |||||||||||||||||||
Cash | $ |
|
$ |
|
$ |
|
|||||||||||||||||
Trade accounts receivable |
|
|
|
||||||||||||||||||||
Other current assets |
|
|
|
||||||||||||||||||||
Property and equipment and other noncurrent assets
|
|
|
|
||||||||||||||||||||
Operating lease assets
|
— |
|
|
||||||||||||||||||||
Non-deductible goodwill |
|
|
|
||||||||||||||||||||
Tax-deductible goodwill |
|
|
|
||||||||||||||||||||
Customer relationship assets |
|
|
|
|
|||||||||||||||||||
Other definite-lived intangible assets
|
|
|
|
|
|||||||||||||||||||
Indefinite-lived intangible assets
|
— |
|
|
||||||||||||||||||||
Operating lease liabilities
|
— |
(
|
(
|
||||||||||||||||||||
Other current liabilities
|
(
|
(
|
(
|
||||||||||||||||||||
Deferred income tax liabilities, net
|
(
|
(
|
(
|
||||||||||||||||||||
Operating lease liabilities, noncurrent
|
— |
(
|
(
|
||||||||||||||||||||
Purchase price | $ |
|
$ |
|
$ |
|
Note 4 — Restructuring Charges |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
(in millions) | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||
Employee separation costs | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Facility exit costs
(1)
|
|
|
|
|
||||||||||||||||||||||
Third party and other costs
(2)
|
|
|
|
|
||||||||||||||||||||||
Total restructuring charges | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Cognizant Technology Solutions |
14
|
September 30, 2024 Form 10-Q
|
(in millions) | 2024 | 2023 | ||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Employee separation costs accrued |
|
|
||||||||||||
Payments made |
(
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
Note 5 — Investments |
(in millions) | September 30, 2024 | December 31, 2023 | |||||||||
Short-term investments: | |||||||||||
Equity investment security | $ |
|
$ |
|
|||||||
Held-to-maturity investment securities |
|
|
|||||||||
Time deposits |
|
|
|||||||||
Total short-term investments | $ |
|
$ |
|
Long-term investments: | |||||||||||
Other investments | $ |
|
$ |
|
|||||||
Restricted time deposits
(1)
|
|
|
|||||||||
Total long-term investments | $ |
|
$ |
|
Cognizant Technology Solutions |
15
|
September 30, 2024 Form 10-Q
|
Note 6 — Accrued Expenses and Other Current Liabilities |
(in millions) | September 30, 2024 | December 31, 2023 | |||||||||
Compensation and benefits | $ |
|
$ |
|
|||||||
Customer volume and other incentives |
|
|
|||||||||
Income taxes |
|
|
|||||||||
Professional fees |
|
|
|||||||||
Other |
|
|
|||||||||
Total accrued expenses and other current liabilities | $ |
|
$ |
|
Note 7 — Debt |
(in millions) | September 30, 2024 | December 31, 2023 | |||||||||
Notes outstanding under revolving credit facility | $ |
|
$ |
|
|||||||
Term Loan |
|
|
|||||||||
Less: | |||||||||||
Current maturities - Term Loan
|
(
|
(
|
|||||||||
Unamortized deferred financing costs |
(
|
(
|
|||||||||
Long-term debt, net of current maturities | $ |
|
$ |
|
Cognizant Technology Solutions |
16
|
September 30, 2024 Form 10-Q
|
Note 8 — Income Taxes |
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Effective income tax rate |
|
% |
|
% |
|
% |
|
% |
Cognizant Technology Solutions |
17
|
September 30, 2024 Form 10-Q
|
Note 9 — Derivative Financial Instruments |
(in millions) | September 30, 2024 | December 31, 2023 | ||||||||||||||||||||||||||||||
Designation of Derivatives |
Location on Statement of
Financial Position |
Assets | Liabilities | Assets | Liabilities | |||||||||||||||||||||||||||
Foreign exchange forward and option contracts – Designated as cash flow hedging instruments | Other current assets | $ |
|
$ | — | $ |
|
$ | — | |||||||||||||||||||||||
Other noncurrent assets |
|
— |
|
— | ||||||||||||||||||||||||||||
Accrued expenses and other current liabilities | — |
|
— |
|
||||||||||||||||||||||||||||
Other noncurrent liabilities | — |
|
— |
|
||||||||||||||||||||||||||||
Total |
|
|
|
|
||||||||||||||||||||||||||||
Foreign exchange forward contracts – Not designated as hedging instruments | Other current assets |
|
— |
|
— | |||||||||||||||||||||||||||
Accrued expenses and other current liabilities | — |
|
— |
|
||||||||||||||||||||||||||||
Total |
|
|
|
|
||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
Cognizant Technology Solutions |
18
|
September 30, 2024 Form 10-Q
|
(in millions) | September 30, 2024 | December 31, 2023 | |||||||||
2024 |
|
$ |
|
||||||||
2025 |
|
|
|||||||||
2026 |
|
|
|||||||||
Total notional value of contracts outstanding
(1)
|
$ |
|
$ |
|
|||||||
(in millions) |
Change in
Derivative Gains and Losses Recognized
in Accumulated Other
Comprehensive Income (Loss)
(effective portion)
|
Location of Net Gains (Losses) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
Net Gains (Losses) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||
Foreign exchange forward and option contracts – Designated as cash flow hedging instruments | $ |
(
|
$ |
(
|
Cost of revenues | $ |
|
$ |
(
|
||||||||||||||||||||
SG&A expenses
|
|
(
|
|||||||||||||||||||||||||||
Total | $ |
|
$ |
(
|
(in millions) |
Change in
Derivative Gains and Losses Recognized
in Accumulated Other
Comprehensive Income (Loss)
(effective portion)
|
Location of Net Gains (Losses) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
Net Gains (Losses) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||
Foreign exchange forward and option contracts – Designated as cash flow hedging instruments | $ |
|
$ |
|
Cost of revenues | $ |
|
$ |
(
|
||||||||||||||||||||
SG&A expenses
|
|
(
|
|||||||||||||||||||||||||||
Total | $ |
|
$ |
(
|
(in millions) | September 30, 2024 | December 31, 2023 | |||||||||||||||||||||
Notional | Fair Value | Notional | Fair Value | ||||||||||||||||||||
Contracts outstanding | $ |
|
$ |
|
$ |
|
$ |
(
|
Cognizant Technology Solutions |
19
|
September 30, 2024 Form 10-Q
|
Location of Net Gains (Losses) on Derivative Instruments
|
Amount of Net Gains (Losses) on Derivative Instruments | ||||||||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||
(in millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||||
Foreign exchange forward contracts – Not designated as hedging instruments | Foreign currency exchange gains (losses), net | $ |
|
$ |
|
$ |
|
$ |
(
|
Note 10 — Fair Value Measurements |
(in millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||
Money market funds | $ |
|
$ | — | $ | — | $ |
|
|||||||||||||||
Time deposits | — |
|
— |
|
|||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||
Time deposits |
|
|
|
|
|||||||||||||||||||
Equity investment security |
|
|
|
|
|||||||||||||||||||
Other current assets: | |||||||||||||||||||||||
Foreign exchange forward contracts
|
|
|
|
|
|||||||||||||||||||
Other noncurrent assets:
|
|||||||||||||||||||||||
Foreign exchange forward contracts |
|
|
|
|
|||||||||||||||||||
Accrued expenses and other current liabilities:
|
|||||||||||||||||||||||
Foreign exchange forward contracts
|
|
(
|
|
(
|
|||||||||||||||||||
Other noncurrent liabilities:
|
|||||||||||||||||||||||
Foreign exchange forward contracts |
|
(
|
|
(
|
|||||||||||||||||||
Cognizant Technology Solutions |
20
|
September 30, 2024 Form 10-Q
|
(in millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||
Money market funds | $ |
|
$ | — | $ | — | $ |
|
|||||||||||||||
Time deposits | — |
|
— |
|
|||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||
Equity investment security |
|
|
|
|
|||||||||||||||||||
Other current assets: | |||||||||||||||||||||||
Foreign exchange forward contracts |
|
|
|
|
|||||||||||||||||||
Long-term investments: | |||||||||||||||||||||||
Restricted time deposits
(1)
|
— |
|
— |
|
|||||||||||||||||||
Other noncurrent assets: | |||||||||||||||||||||||
Foreign exchange forward contracts |
|
|
|
|
|||||||||||||||||||
Accrued expenses and other current liabilities: | |||||||||||||||||||||||
Foreign exchange forward contracts |
|
(
|
|
(
|
|||||||||||||||||||
Contingent consideration liabilities |
|
|
(
|
(
|
|||||||||||||||||||
Other noncurrent liabilities: | |||||||||||||||||||||||
Foreign exchange forward contracts |
|
(
|
|
(
|
|||||||||||||||||||
(in millions) | September 30, 2024 | September 30, 2023 | ||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Change in fair value recognized in SG&A expenses |
|
|
||||||||||||
Payments |
(
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
Cognizant Technology Solutions |
21
|
September 30, 2024 Form 10-Q
|
Note 11 — Accumulated Other Comprehensive Income (Loss) |
Three Months |
Nine Months
|
|||||||||||||||||||||||||||||||||||||
(in millions) |
Before Tax
Amount |
Tax
Effect |
Net of Tax
Amount |
Before Tax
Amount |
Tax
Effect |
Net of Tax
Amount |
||||||||||||||||||||||||||||||||
Foreign currency translation adjustments: | ||||||||||||||||||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Change in foreign currency translation adjustments |
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||
Ending balance | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Unrealized gains on cash flow hedges:
|
||||||||||||||||||||||||||||||||||||||
Beginning balance | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||
Unrealized (losses) gains arising during the period
|
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
Reclassifications of net gains to:
|
||||||||||||||||||||||||||||||||||||||
Cost of revenues |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
SG&A expenses |
|
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Net change |
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
Ending balance | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||
Accumulated other comprehensive income (loss): | ||||||||||||||||||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Other comprehensive income (loss) |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Ending balance | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Three Months |
Nine Months
|
|||||||||||||||||||||||||||||||||||||
(in millions) |
Before Tax
Amount |
Tax
Effect |
Net of Tax
Amount |
Before Tax
Amount |
Tax
Effect |
Net of Tax
Amount |
||||||||||||||||||||||||||||||||
Foreign currency translation adjustments: | ||||||||||||||||||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Change in foreign currency translation adjustments |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||
Ending balance | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Unrealized gains and losses on cash flow hedges: | ||||||||||||||||||||||||||||||||||||||
Beginning balance | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Unrealized (losses) gains arising during the period
|
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
Reclassifications of net loss to:
|
||||||||||||||||||||||||||||||||||||||
Cost of revenues |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
SG&A expenses |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
Net change |
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
Ending balance | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Accumulated other comprehensive income (loss): | ||||||||||||||||||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Other comprehensive income (loss) |
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
Ending balance | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
Cognizant Technology Solutions |
22
|
September 30, 2024 Form 10-Q
|
Note 12— Commitments and Contingencies |
Cognizant Technology Solutions |
23
|
September 30, 2024 Form 10-Q
|
Cognizant Technology Solutions |
24
|
September 30, 2024 Form 10-Q
|
Note 13 — Segment Information |
Cognizant Technology Solutions |
25
|
September 30, 2024 Form 10-Q
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
(in millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Financial Services | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Health Sciences |
|
|
|
|
|||||||||||||||||||
Products and Resources |
|
|
|
|
|||||||||||||||||||
Communications, Media and Technology |
|
|
|
|
|||||||||||||||||||
Total segment operating profit |
|
|
|
|
|||||||||||||||||||
Less: unallocated costs |
|
|
|
|
|||||||||||||||||||
Income from operations | $ |
|
$ |
|
$ |
|
$ |
|
As of | |||||||||||
(in millions) | September 30, 2024 | December 31, 2023 | |||||||||
Long-lived Assets:
(1)
|
|||||||||||
North America
(2)
|
$ |
|
$ |
|
|||||||
Europe |
|
|
|||||||||
Rest of World
(3)
|
|
|
|||||||||
Total | $ |
|
$ |
|
Note 14 — Subsequent Events |
Cognizant Technology Solutions |
26
|
September 30, 2024 Form 10-Q
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
Executive Summary |
Revenue |
Income from Operations |
Operating Margin |
Diluted EPS |
GAAP |
Adjusted
1
|
GAAP |
Adjusted
1
|
GAAP |
Adjusted
1
|
Revenue up $147 million or 3.0% from Q3 2023; an increase of 2.7% in constant currency
1
|
Income from Operations up $52 million or 7.6% from Q3 2023
Adjusted Income from Operations
1
up $13 million or 1.7% from Q3 2023
|
Operating margin up 60 bps from Q3 2023
Adjusted Operating Margin
1
down 20 bps from Q3 2023
|
Diluted EPS up $0.13 or 12.5% from Q3 2023
Adjusted Diluted EPS
1
up $0.09 or 7.8% from Q3 2023
|
|||||||||||||||||||||||||||||||||||
Cognizant Technology Solutions |
27
|
September 30, 2024 Form 10-Q
|
Cognizant Technology Solutions |
28
|
September 30, 2024 Form 10-Q
|
Results of Operations |
% of | % of | Increase / Decrease | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions, except per share data) | 2024 | Revenues | 2023 | Revenues | $ | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues | $ | 5,044 | 100.0 | $ | 4,897 | 100.0 | $ | 147 | 3.0 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Cost of revenues
(a)
|
3,311 | 65.6 | 3,209 | 65.5 | 102 | 3.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Selling, general and administrative expenses
(a)
|
833 | 16.5 | 801 | 16.4 | 32 | 4.0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring charges | 33 | 0.7 | 72 | 1.5 | (39) | (54.2) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization expense | 129 | 2.6 | 129 | 2.6 | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Income from operations | 738 | 14.6 | 686 | 14.0 | 52 | 7.6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Other income (expense), net | 10 | 27 | (17) | (63.0) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income before provision for income taxes | 748 | 14.8 | 713 | 14.6 | 35 | 4.9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Provision for income taxes | (170) | (191) | 21 | (11.0) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income (loss) from equity method investments | 4 | 3 | 1 | 33.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income | $ | 582 | 11.5 | $ | 525 | 10.7 | $ | 57 | 10.9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Diluted EPS
|
$ | 1.17 | $ | 1.04 | $ | 0.13 | 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Financial Information
3
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted Income from Operations and Adjusted Operating Margin | $ | 771 | 15.3 | $ | 758 | 15.5 | $ | 13 | 1.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted Diluted EPS | $ | 1.25 | $ | 1.16 | $ | 0.09 | 7.8 |
Revenues
|
Cognizant Technology Solutions |
29
|
September 30, 2024 Form 10-Q
|
Revenues - Reportable Business Segments and Geographic Markets
|
Q3 2024 as compared to Q3 2023
|
Increase / (Decrease) | ||||||||||||||||||||||||||||||||||
(Dollars in millions) | $ | % |
CC %
4
|
||||||||||||||||||||||||||||||||
Financial Services | $ | 11 | 0.7 | 0.5 | |||||||||||||||||||||||||||||||
Health Sciences | 109 | 7.8 | 7.6 | ||||||||||||||||||||||||||||||||
Products and Resources | 58 | 5.0 | 4.6 | ||||||||||||||||||||||||||||||||
CMT | (31) | (3.7) | (4.1) | ||||||||||||||||||||||||||||||||
Total revenues | $ | 147 | 3.0 | 2.7 |
Q3 2024 as compared to Q3 2023
|
Increase / (Decrease) | ||||||||||||||||||||||||||||||||||
(Dollars in millions) | $ | % |
CC %
4
|
||||||||||||||||||||||||||||||||
North America | $ | 136 | 3.8 | 3.8 | |||||||||||||||||||||||||||||||
United Kingdom | (4) | (0.8) | (2.9) | ||||||||||||||||||||||||||||||||
Continental Europe | 1 | 0.2 | (0.8) | ||||||||||||||||||||||||||||||||
Europe - Total | (3) | (0.3) | (1.9) | ||||||||||||||||||||||||||||||||
Rest of World | 14 | 4.3 | 4.2 | ||||||||||||||||||||||||||||||||
Total revenues | $ | 147 | 3.0 | 2.7 |
Cognizant Technology Solutions |
30
|
September 30, 2024 Form 10-Q
|
Cost of Revenues (Exclusive of Depreciation and Amortization Expense)
|
é |
$102M
|
|||||||||||||
é |
0.1% as a % of revenues
|
|||||||||||||
¡ | % of Revenues | |||||||||||||
SG&A Expenses (Exclusive of Depreciation and Amortization Expense)
|
é |
$32M
|
|||||||||||||
é |
0.1% as a % of revenues
|
|||||||||||||
¡ | % of Revenues | |||||||||||||
Restructuring Charges
|
Depreciation and Amortization Expense
|
Operating Margin and Adjusted Operating Margin
5
- Overall
|
Cognizant Technology Solutions |
31
|
September 30, 2024 Form 10-Q
|
Segment Operating Profit
|
Segment operating profit | % | Segment operating margin |
(Dollars in millions) | 2024 | % of Revenues | 2023 | % of Revenues |
Increase/(Decrease)
|
|||||||||||||||||||||||||||
Total segment operating profit | $ | 1,091 | 21.6 | $ | 1,036 | 21.2 | $ | 55 | ||||||||||||||||||||||||
Less: unallocated costs | 353 | 7.0 | 350 | 7.2 | 3 | |||||||||||||||||||||||||||
Income from operations | $ | 738 | 14.6 | $ | 686 | 14.0 | $ | 52 | ||||||||||||||||||||||||
Cognizant Technology Solutions |
32
|
September 30, 2024 Form 10-Q
|
Other Income (Expense), Net
|
(in millions) | 2024 | 2023 |
Increase/
Decrease |
||||||||||||||||||||
Foreign currency exchange (losses) | $ | (22) | $ | (23) | $ | 1 | |||||||||||||||||
Gains on foreign exchange forward contracts not designated as hedging instruments | 14 | 23 | (9) | ||||||||||||||||||||
Foreign currency exchange gains (losses), net | (8) | — | (8) | ||||||||||||||||||||
Interest income | 31 | 32 | (1) | ||||||||||||||||||||
Interest expense | (14) | (11) | (3) | ||||||||||||||||||||
Other, net | 1 | 6 | (5) | ||||||||||||||||||||
Total other income (expense), net | $ | 10 | $ | 27 | $ | (17) |
Provision for Income Taxes
|
ê |
$21M
|
|||||||||||||
¡
Effective Income Tax Rate
ê
4.1%
|
||||||||||||||
Net Income
|
é |
$57M
|
|||||||||||||
¡
é
0.8% of Revenue
s
|
||||||||||||||
Cognizant Technology Solutions |
33
|
September 30, 2024 Form 10-Q
|
2024 |
% of
Revenues |
2023 |
% of
Revenues |
||||||||||||||||||||
GAAP income from operations and operating margin | $ | 738 | 14.6 | $ | 686 | 14.0 | |||||||||||||||||
NextGen charges
(1)
|
33 | 0.7 | 72 | 1.5 | |||||||||||||||||||
Adjusted Income from Operations and Adjusted Operating Margin | $ | 771 | 15.3 | $ | 758 | 15.5 | |||||||||||||||||
GAAP diluted EPS | $ | 1.17 | $ | 1.04 | |||||||||||||||||||
Effect of NextGen charges, pre-tax | 0.07 | 0.14 | |||||||||||||||||||||
Non-operating foreign currency exchange (gains) losses, pre-tax
(2)
|
0.02 | — | |||||||||||||||||||||
Tax effect of above adjustments
(3)
|
(0.01) | (0.02) | |||||||||||||||||||||
Adjusted Diluted EPS | $ | 1.25 | $ | 1.16 | |||||||||||||||||||
Three Months Ended
September 30, |
|||||||||||
(in millions) | 2024 | 2023 | |||||||||
Non-GAAP income tax benefit (expense) related to: | |||||||||||
NextGen charges | $ | 8 | $ | 18 | |||||||
Foreign currency exchange gains and losses | (3) | (7) |
Cognizant Technology Solutions |
34
|
September 30, 2024 Form 10-Q
|
% of | % of | Increase / Decrease | |||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions, except per share data) | 2024 | Revenues | 2023 | Revenues | $ | % | |||||||||||||||||||||||||||||||||||||||||
Revenues | $ | 14,654 | 100.0 | $ | 14,595 | 100.0 | $ | 59 | 0.4 | ||||||||||||||||||||||||||||||||||||||
Cost of revenues
(a)
|
9,661 | 65.9 | 9,583 | 65.7 | 78 | 0.8 | |||||||||||||||||||||||||||||||||||||||||
Selling, general and administrative expenses
(a)
|
2,379 | 16.2 | 2,466 | 16.9 | (87) | (3.5) | |||||||||||||||||||||||||||||||||||||||||
Restructuring charges | 85 | 0.6 | 189 | 1.3 | (104) | (55.0) | |||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization expense | 388 | 2.6 | 392 | 2.7 | (4) | (1.0) | |||||||||||||||||||||||||||||||||||||||||
Income from operations | 2,141 | 14.6 | 1,965 | 13.5 | 176 | 9.0 | |||||||||||||||||||||||||||||||||||||||||
Other income (expense), net | 57 | 73 | (16) | (21.9) | |||||||||||||||||||||||||||||||||||||||||||
Income before provision for income taxes | 2,198 | 15.0 | 2,038 | 14.0 | 160 | 7.9 | |||||||||||||||||||||||||||||||||||||||||
Provision for income taxes | (514) | (473) | (41) | 8.7 | |||||||||||||||||||||||||||||||||||||||||||
Income (loss) from equity method investments | 10 | 3 | 7 | 233.3 | |||||||||||||||||||||||||||||||||||||||||||
Net income | $ | 1,694 | 11.6 | $ | 1,568 | 10.7 | $ | 126 | 8.0 | ||||||||||||||||||||||||||||||||||||||
Diluted EPS | $ | 3.41 | $ | 3.09 | $ | 0.32 | 10.4 | ||||||||||||||||||||||||||||||||||||||||
Other Financial Information
6
|
|||||||||||||||||||||||||||||||||||||||||||||||
Adjusted Income From Operations and Adjusted Operating Margin
|
$ | 2,226 | 15.2 | $ | 2,154 | 14.8 | $ | 72 | 3.3 | ||||||||||||||||||||||||||||||||||||||
Adjusted Diluted EPS | $ | 3.55 | $ | 3.37 | $ | 0.18 | 5.3 |
Revenues |
Cognizant Technology Solutions |
35
|
September 30, 2024 Form 10-Q
|
Revenues - Reportable Business Segments and Geographic Markets
|
YTD 2024 as compared to YTD 2023
|
Increase / (Decrease) | |||||||||||||||||||||||||||||||
(Dollars in millions) | $ | % |
CC %
7
|
|||||||||||||||||||||||||||||
Financial Services | $ | (96) | (2.2) | (2.3) | ||||||||||||||||||||||||||||
Health Sciences | 113 | 2.6 | 2.6 | |||||||||||||||||||||||||||||
Products and Resources | 22 | 0.6 | 0.5 | |||||||||||||||||||||||||||||
CMT | 20 | 0.8 | 0.6 | |||||||||||||||||||||||||||||
Total revenues | $ | 59 | 0.4 | 0.3 |
YTD 2024 as compared to YTD 2023
|
Increase / (Decrease) | |||||||||||||||||||||||||||||||
(Dollars in millions) | $ | % |
CC %
7
|
|||||||||||||||||||||||||||||
North America | $ | 143 | 1.3 | 1.4 | ||||||||||||||||||||||||||||
United Kingdom | (55) | (3.8) | (5.7) | |||||||||||||||||||||||||||||
Continental Europe | (1) | (0.1) | (0.7) | |||||||||||||||||||||||||||||
Europe - Total | (56) | (1.9) | (3.2) | |||||||||||||||||||||||||||||
Rest of World | (28) | (2.8) | (1.2) | |||||||||||||||||||||||||||||
Total revenues | $ | 59 | 0.4 | 0.3 |
Cognizant Technology Solutions |
36
|
September 30, 2024 Form 10-Q
|
Cost of Revenues (Exclusive of Depreciation and Amortization Expense)
|
é |
$78M
|
|||||||||||||
é |
0.2% as a % of revenues
|
|||||||||||||
¡ | % of Revenues | |||||||||||||
SG&A Expenses (Exclusive of Depreciation and Amortization Expense)
|
ê |
$87M
|
|||||||||||||
ê |
0.7%
as a % of revenues
|
|||||||||||||
¡ | % of Revenues | |||||||||||||
Restructuring Charges
|
Depreciation and Amortization Expense
|
Operating Margin and Adjusted Operating Margin
8
- Overall
|
Cognizant Technology Solutions |
37
|
September 30, 2024 Form 10-Q
|
Segment Operating Profit
|
Segment operating profit | % | Segment operating margin |
(Dollars in millions) | 2024 | % of Revenues | 2023 | % of Revenues |
Increase/(Decrease)
|
||||||||||||||||||||||||
Total segment operating profit | $ | 3,034 | 20.7 | $ | 3,054 | 20.9 | $ | (20) | |||||||||||||||||||||
Less: unallocated costs | 893 | 6.1 | 1,089 | 7.4 | (196) | ||||||||||||||||||||||||
Income from operations | $ | 2,141 | 14.6 | $ | 1,965 | 13.5 | $ | 176 | |||||||||||||||||||||
Cognizant Technology Solutions |
38
|
September 30, 2024 Form 10-Q
|
Other Income (Expense), Net
|
(in millions) | 2024 | 2023 |
Increase/
Decrease |
||||||||||||||||||||
Foreign currency exchange (losses) gains | $ | (43) | $ | 4 | $ | (47) | |||||||||||||||||
Gains (losses) on foreign exchange forward contracts not designated as hedging instruments | 42 | (1) | 43 | ||||||||||||||||||||
Foreign currency exchange gains (losses), net | (1) | 3 | (4) | ||||||||||||||||||||
Interest income | 91 | 92 | (1) | ||||||||||||||||||||
Interest expense | (35) | (30) | (5) | ||||||||||||||||||||
Other, net | 2 | 8 | (6) | ||||||||||||||||||||
Total other income (expense), net | $ | 57 | $ | 73 | $ | (16) |
Provision for Income Taxes
|
é |
$41M
|
|||||||||||||
¡
Effective Income Tax Rate
é
0.2%
|
||||||||||||||
Net Income
|
é |
$126M
|
||||||||||||||||
¡
é
0.9% of Revenues
|
|||||||||||||||||
Cognizant Technology Solutions |
39
|
September 30, 2024 Form 10-Q
|
(Dollars in millions, except per share amounts) | 2024 |
% of
Revenues |
2023 |
% of
Revenues |
|||||||||||||||||||
GAAP income from operations and operating margin | $ | 2,141 | 14.6 | $ | 1,965 | 13.5 | |||||||||||||||||
NextGen charges
(1)
|
85 | 0.6 | 189 | 1.3 | |||||||||||||||||||
Adjusted Income from Operations and Adjusted Operating Margin | $ | 2,226 | 15.2 | $ | 2,154 | 14.8 | |||||||||||||||||
GAAP diluted EPS | $ | 3.41 | $ | 3.09 | |||||||||||||||||||
Effect of NextGen charges, pre-tax | 0.17 | 0.37 | |||||||||||||||||||||
Non-operating foreign currency exchange (gains) losses, pre-tax
(2)
|
— | (0.01) | |||||||||||||||||||||
Tax effect of above adjustments
(3)
|
(0.03) | (0.08) | |||||||||||||||||||||
Adjusted Diluted EPS | $ | 3.55 | $ | 3.37 | |||||||||||||||||||
(in millions) |
Nine Months Ended
September 30, |
||||||||||
2024 | 2023 | ||||||||||
Non-GAAP income tax benefit (expense) related to: | |||||||||||
NextGen charges | $ | 21 | $ | 49 | |||||||
Foreign currency exchange gains and losses | (3) | (2) |
Liquidity and Capital Resources |
(in millions) | 2024 | 2023 | Increase / Decrease | ||||||||||||||||||||||||||
Net cash provided by (used in): | |||||||||||||||||||||||||||||
Operating activities | $ | 1,204 | $ | 1,593 | $ | (389) | |||||||||||||||||||||||
Investing activities | (1,567) | (499) | (1,068) | ||||||||||||||||||||||||||
Financing activities | (313) | (1,154) | 841 | ||||||||||||||||||||||||||
Cognizant Technology Solutions |
40
|
September 30, 2024 Form 10-Q
|
Acquisitions | |||||
Share Repurchases | |||||
Dividend payments | |||||
Cognizant Technology Solutions |
41
|
September 30, 2024 Form 10-Q
|
Commitments and Contingencies |
Critical Accounting Estimates |
Recently Adopted and New Accounting Pronouncements |
Item 3. Quantitative and Qualitative Disclosures about Market Risk. |
Item 4. Controls and Procedures. |
Cognizant Technology Solutions |
42
|
September 30, 2024 Form 10-Q
|
Item 1. Legal Proceedings |
Item 1A. Risk Factors |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
Month |
Total Number
of Shares Purchased |
Average
Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |
Approximate Dollar Value of Shares that May Yet Be Purchased under the Plans or Programs
(in millions) |
||||||||||||||||||||||
July 1, 2024 - July 31, 2024
|
1,244,604 | $ | 70.30 | 1,244,604 | $ | 1,517 | ||||||||||||||||||||
August 1, 2024 - August 31, 2024
|
1,087,827 | 75.19 | 1,087,827 | 1,436 | ||||||||||||||||||||||
September 1, 2024 - September 30, 2024
|
763,262 | 76.26 | 763,262 | 1,377 | ||||||||||||||||||||||
Total | 3,095,693 | $ | 73.49 | 3,095,693 |
Item 5. Other Information |
Name
|
Title
|
Action
|
Date of adoption/termination
|
Scheduled expiration date
1
|
Aggregate number of securities to be purchased/sold
|
|||||||||||||||||||||||||||
|
|
|
|
December 4, 2025 |
Sale of up to
|
|||||||||||||||||||||||||||
|
|
|
|
December 22, 2024 |
Sale of up to
|
Cognizant Technology Solutions |
43
|
September 30, 2024 Form 10-Q
|
Item 6. Exhibit Index |
Incorporated by Reference | ||||||||||||||||||||||||||||||||||||||
Number | Exhibit Description | Form | File No. | Exhibit | Date | Filed or Furnished Herewith | ||||||||||||||||||||||||||||||||
2.1 | 8-K | 000-24429 | 2.1 | 6/10/2024 | ||||||||||||||||||||||||||||||||||
3.1 | 8-K | 000-24429 | 3.1 | 6/7/2024 | ||||||||||||||||||||||||||||||||||
3.2 | 8-K | 000-24429 | 3.1 | 9/20/2018 | ||||||||||||||||||||||||||||||||||
10.1 |
Filed
|
|||||||||||||||||||||||||||||||||||||
31.1 | Filed | |||||||||||||||||||||||||||||||||||||
31.2 | Filed | |||||||||||||||||||||||||||||||||||||
32.1 | Furnished | |||||||||||||||||||||||||||||||||||||
32.2 | Furnished | |||||||||||||||||||||||||||||||||||||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | Filed | ||||||||||||||||||||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | Filed | ||||||||||||||||||||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | Filed | ||||||||||||||||||||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | Filed | ||||||||||||||||||||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | Filed | ||||||||||||||||||||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | Filed | ||||||||||||||||||||||||||||||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | Filed |
Cognizant Technology Solutions |
44
|
September 30, 2024 Form 10-Q
|
Cognizant Technology Solutions Corporation | ||||||||||||||||||||
Date: | October 30, 2024 | By: |
/s/ R
AVI
K
UMAR
S
|
|||||||||||||||||
Ravi Kumar S, | ||||||||||||||||||||
Chief Executive Officer | ||||||||||||||||||||
(Principal Executive Officer) |
Date: | October 30, 2024 | By: |
/s/ J
ATIN
D
ALAL
|
|||||||||||||||||
Jatin Dalal,
|
||||||||||||||||||||
Chief Financial Officer | ||||||||||||||||||||
(Principal Financial Officer) |
Cognizant Technology Solutions |
45
|
September 30, 2024 Form 10-Q
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
KeyCorp | KEY |
KeyCorp | KEY |
Microsoft Corporation | MSFT |
UnitedHealth Group Incorporated | UNH |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|